Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Onychomycosis - Drug Pipeline Landscape, 2023
... underneath the nail, proximal subungual or white superficial with spreading of chalky white scale beneath the nail surface. Onychomycosis is caused by 3 main classes of fungi: dermatophytes, yeasts, and non-dermatophyte molds. Dermatophytes are by ... Read More
-
Acromegaly - Drug Pipeline Landscape, 2023
... bones and soft tissues of the body. Children with the condition can grow to abnormal heights. The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes ... Read More
-
Hepatitis D (HDV) - Drug Pipeline Landscape, 2023
... D infection cannot occur in the absence of hepatitis B virus. HDV-HBV co-infection is considered the most severe form of chronic viral hepatitis due to more rapid progression towards hepatocellular carcinoma and liver-related death. The ... Read More
-
Lassa Fever - Drug Pipeline Landscape, 2023
... bleeding without any symptoms. Lassa fever virus is a disease that is animal-borne or spread to humans from animals. It is spread to people through contact with household items, food, water, or air contaminated with ... Read More
-
Oral Mucositis - Drug Pipeline Landscape, 2023
... cause of Oral Mucositis is cancer treatments. The frequent treatments of chemotherapy, radiation of the head, chest, or neck, bone marrow and stem cell transplants can cause mucositis. Symptoms include dry mouth, shiny, swollen, or ... Read More
-
Lyme Disease - Drug Pipeline Landscape, 2023
... rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 460,000 diagnosed incident cases of bladder cancer across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of bladder cancer, mostly checkpoint inhibitors. The bladder cancer ... Read More
-
Benign Prostatic Hyperplasia - Drug Pipeline Landscape, 2023
... urinary symptoms, such as blocking the flow of urine out of the bladder. The common causes of BPH include changes in male sex hormones, any family history of prostate problems or any abnormalities with testicles ... Read More
-
Clinical Trials in 2023 - A Preview of Trials Planned to Initiate and Estimated to Complete in 2023
... to be completed in 2023. Scope The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included planned clinical trials with a start date from January 1 to ... Read More
-
Clinical Trial Packaging and Labelling Market Report 2023-2033
... understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Number of Clinical ... Read More
-
Chemotherapy induced diarrhea - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the CID market trends in the United States, EU4 and the UK and Japan. The Chemotherapy-induced Diarrhea (CID) market report provides current treatment practices, emerging drugs, CID market share of ... Read More
-
Idiopathic Inflammatory Myopathies
... market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential ... Read More
-
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
... a defect in insulin secretion and sensitivity, whereby the β-cells in the pancreas fail to secrete sufficient amounts of insulin and cells fail to uptake adequate amounts of insulin due to loss of sensitivity, commonly ... Read More
-
B-Cell Non-Hodgkins Lymphoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and China) for marketed and pipeline therapies with established mechanisms of action by class, including early to ... Read More
-
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 26.9 million diagnosed incidence cases of SIT are expected across 16 pharmaceutical markets. Roche’s Xofluza (baloxavir) was the most recent entry to the influenza market. The influenza pipeline consists of 108 pharmaceutical therapies spanning ... Read More
-
Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Liver Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Peripheral Artery Occlusive Disease (PAOD) Clinical trials scenario. This report provides ... Read More
-
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Non Alcoholic Fatty Liver Disease (NAFLD) Clinical trials scenario. ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 180,000 diagnosed prevalent cases of CIDP across 16 pharmaceutical markets. The majority of marketed drugs for the treatment of CIDP fall into the human immunoglobulins category. There are only six ... Read More
-
Rhinosinusitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Rhinosinusitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Rhinosinusitis. Report includes ... Read More
-
Pulmonary Arterial Hypertension Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Pulmonary Arterial Hypertension Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Influenzavirus B Infections Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 1.3 billion total prevalent cases of NAFLD across 16 pharmaceutical markets. Currently, there are no FDA or EMA approved drugs for NAFLD. The NAFLD pipeline consists of 145 pharmaceuticals spanning ... Read More
-
Dry Eye Syndrome Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2018-2028
... is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics ... Read More
-
Colorectal Cancer Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment by ... Read More
Research Assistance
